NeurologyLive® Friday 5 — September 25, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Don’t have time to read or watch a full video interview? Click here to check out our shorts!

Click the read more or watch now buttons for more details and information about each highlight.

1: Closing the Gaps in Cluster Headache Care: Jennifer Fokas, MD; Minali Nigam, MD

In a recent video interview, Jennifer Fokas, MD, and Minali Nigam, MD, both neurologists at Northwestern Medicine, discussed the unmet needs in cluster headache and the diagnostic overlap with migraine that can delay care for patients. [WATCH TIME: 5 minutes]

2: Exploring the Link Between Football Players and ALS: Brian Lin, PhD

In a recent Q&A interview, Brian Lin, PhD, research portfolio director at the Muscular Dystrophy Association, discussed the current evidence linking football participation with ALS, the questions that remain unanswered, and how emerging research may help clarify the association.

3: Improving the Transition From Pediatric to Adult Epilepsy Care

In a recent video program episode, Jacqueline French, MD, professor of neurology at NYU Grossman School of Medicine, discussed how moving from pediatric to adult epilepsy care can disrupt years of accumulated clinical knowledge, and outlined how stronger handoffs can help preserve continuity.

4: NeuroVoices: Eva Mistry, MD, on Addressing Secondary Stroke Prevention Gaps in Underserved Populations

In our latest NeuroVoices, Eva Mistry, MD, a professor of neurology at the University of Cincinnati, discussed why disparities persist in secondary stroke prevention and how growing awareness of social determinants of health is helping to close the gap for underserved patients.

5: Unmet Needs and Mechanisms Behind Newer Agitation Therapies

In a recent video program episode, Alzheimer disease experts Marwan Sabbagh, MD; Amita Patel, MD, CMD, MHA, CPE; Erin Crown, MHS, PA-C, Psych-CAQ; David Liporace, DO; Laura Melaro, DNP, APRN, FNP-BC, PMHNP-BC, weigh the field's remaining unmet needs against the biological rationale behind a newer, nonantipsychotic approach to treatment.